A Randomized, Double-Blind, Placebo-Controlled, Phase 1 Trial of Radiopaque Islatravir-Eluting Subdermal Implants for Pre-exposure Prophylaxis Against HIV-1 Infection.
Matthews RP, Zang X, Barrett SE, Koynov A, Goodey A, Heimbach T, Weissler VL, Leyssens C, Reynders T, Xu Z, Rottey S, Vargo R, Robertson MN, Stoch SA, Iwamoto M.
Matthews RP, et al. Among authors: zang x.
J Acquir Immune Defic Syndr. 2023 Apr 1;92(4):310-316. doi: 10.1097/QAI.0000000000003135. Epub 2022 Nov 29.
J Acquir Immune Defic Syndr. 2023.
PMID: 36450129
Free PMC article.
Clinical Trial.